Related Experiment Video
Updated: Feb 15, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity
I YIlmaz1, M Türk1, S Nazik Bahçecioğlu1
1Erciyes University School of Medicine, Department of Chest Diseases, Division of Allergy and Clinical Immunology, Kayseri, Turkey.
Summary:
Anakinra, one of the novel biological agents, is a recombinant human IL-1 receptor antagonist. It is preferred as an alternative drug for familial Mediterranean fever cases where colchicine is not sufficient or cannot be used due to its side effects. Like all other biologics, hypersensitivity reactions to anakinra are quite rare. This is the first case which was successfully desensitized with anakinra after a severe immediate-type hypersensitivity reaction.
Related Concept Videos
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Ecological Succession
GPCR Desensitization
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

